• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Moving Forward with Omission of Breast Cancer Surgery Following Neoadjuvant Systemic Therapy.

作者信息

Kuerer Henry M

机构信息

MD Anderson Cancer Network Breast Programs, Division of Surgery, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

出版信息

Ann Surg Oncol. 2022 Dec;29(13):7942-7944. doi: 10.1245/s10434-022-12455-7. Epub 2022 Aug 24.

DOI:10.1245/s10434-022-12455-7
PMID:36002702
Abstract
摘要

相似文献

1
Moving Forward with Omission of Breast Cancer Surgery Following Neoadjuvant Systemic Therapy.新辅助全身治疗后省略乳腺癌手术的进展
Ann Surg Oncol. 2022 Dec;29(13):7942-7944. doi: 10.1245/s10434-022-12455-7. Epub 2022 Aug 24.
2
Important considerations prior to elimination of breast cancer surgery after neoadjuvant systemic therapy: Listening to what our patients want.新辅助全身治疗后取消乳腺癌手术前的重要考量：倾听患者的需求。
Ann Oncol. 2020 Aug;31(8):1083-1084. doi: 10.1016/j.annonc.2020.04.009. Epub 2020 Apr 25.
3
Patients should be the tipping point of individualizing breast cancer surgery: Commentary on 'Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges'.患者应成为乳腺癌手术个体化的转折点：对《新辅助全身治疗后摒弃乳腺癌手术模式：当前证据与未来挑战》的评论
Ann Oncol. 2020 Sep;31(9):1264. doi: 10.1016/j.annonc.2020.05.021. Epub 2020 May 28.
4
Optimal Selection of Breast Cancer Patients for Elimination of Surgery Following Neoadjuvant Systemic Therapy.新辅助全身治疗后乳腺癌患者手术切除的最佳选择
Ann Surg. 2018 Dec;268(6):e61-e62. doi: 10.1097/SLA.0000000000002573.
5
Breast conservation following neoadjuvant therapy for breast cancer in the modern era: Are we losing the opportunity?现代乳腺癌新辅助治疗后的保乳治疗：我们正在错失良机吗？
Eur J Surg Oncol. 2016 Dec;42(12):1780-1786. doi: 10.1016/j.ejso.2016.10.011. Epub 2016 Oct 29.
6
Factors affecting surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial.新辅助治疗后原发性HER2阳性乳腺癌患者手术管理的影响因素：NeoALTTO III期试验结果
Ann Oncol. 2014 Apr;25(4):910-911. doi: 10.1093/annonc/mdu034.
7
Quality assessment of neoadjuvant therapy use in breast conservation: barriers to implementation.新辅助治疗在保乳治疗中的应用质量评估：实施障碍。
Breast J. 2009 Sep-Oct;15(5):524-6. doi: 10.1111/j.1524-4741.2009.00771.x. Epub 2009 Jul 31.
8
[Evaluation of neoadjuvant therapy in breast carcinoma].[乳腺癌新辅助治疗的评估]
Chirurg. 2000 Dec;71(12):1458-65. doi: 10.1007/s001040051244.
9
Letter to the editor on 'Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial'.
Ann Oncol. 2014 Apr;25(4):909-910. doi: 10.1093/annonc/mdu030. Epub 2014 Mar 7.
10
Time to surgery among women treated with neoadjuvant systemic therapy and upfront surgery for breast cancer.接受新辅助全身治疗和乳腺癌 upfront 手术的女性患者的手术时间。 （注：这里“upfront surgery”可能有更准确专业术语表述，若能结合更多背景信息会翻译得更精准，比如“初始手术”等，这里暂且按字面意思翻译）
Breast Cancer Res Treat. 2021 Apr;186(2):535-550. doi: 10.1007/s10549-020-06012-7. Epub 2020 Nov 18.

引用本文的文献

1
A machine learning-based algorithm to eliminate breast and axillary surgery in patients with breast cancer and pathological complete response after neoadjuvant chemotherapy.一种基于机器学习的算法，用于消除新辅助化疗后达到病理完全缓解的乳腺癌患者的乳房和腋窝手术。
Ann Transl Med. 2023 Oct 25;11(11):397. doi: 10.21037/atm-23-689. Epub 2023 Mar 6.

本文引用的文献

1
Intelligent Vacuum-Assisted Biopsy to Identify Breast Cancer Patients With Pathologic Complete Response (ypT0 and ypN0) After Neoadjuvant Systemic Treatment for Omission of Breast and Axillary Surgery.智能真空辅助活检识别新辅助全身治疗后省略乳房和腋窝手术的乳腺癌患者的病理完全缓解（ypT0 和 ypN0）。
J Clin Oncol. 2022 Jun 10;40(17):1903-1915. doi: 10.1200/JCO.21.02439. Epub 2022 Feb 2.
2
Vacuum-Assisted Breast Biopsy After Neoadjuvant Systemic Treatment for Reliable Exclusion of Residual Cancer in Breast Cancer Patients.新辅助全身治疗后的真空辅助乳腺活检，用于可靠排除乳腺癌患者的残留癌。
Ann Surg Oncol. 2022 Feb;29(2):1076-1084. doi: 10.1245/s10434-021-10847-9. Epub 2021 Sep 28.
3
Accuracy of Magnetic Resonance Imaging-Guided Biopsy to Verify Breast Cancer Pathologic Complete Response After Neoadjuvant Chemotherapy: A Nonrandomized Controlled Trial.
磁共振成像引导下活检对新辅助化疗后乳腺癌病理完全缓解的准确性：一项非随机对照试验。
JAMA Netw Open. 2021 Jan 4;4(1):e2034045. doi: 10.1001/jamanetworkopen.2020.34045.
4
Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox.早期乳腺癌患者在接受初始全身治疗后的乳房保留和腋窝管理：卢塞恩工具箱。
Lancet Oncol. 2021 Jan;22(1):e18-e28. doi: 10.1016/S1470-2045(20)30580-5.
5
Identification of breast cancer patients with pathologic complete response in the breast after neoadjuvant systemic treatment by an intelligent vacuum-assisted biopsy.智能真空辅助活检识别新辅助全身治疗后乳腺病理完全缓解的乳腺癌患者。
Eur J Cancer. 2021 Jan;143:134-146. doi: 10.1016/j.ejca.2020.11.006. Epub 2020 Dec 8.
6
Minimally Invasive Complete Response Assessment of the Breast After Neoadjuvant Systemic Therapy for Early Breast Cancer (MICRA trial): Interim Analysis of a Multicenter Observational Cohort Study.早期乳腺癌新辅助全身治疗后乳房的微创完全缓解评估（MICRA 试验）：多中心观察队列研究的中期分析。
Ann Surg Oncol. 2021 Jun;28(6):3243-3253. doi: 10.1245/s10434-020-09273-0. Epub 2020 Dec 2.
7
Accuracy of Post-Neoadjuvant Chemotherapy Image-Guided Breast Biopsy to Predict Residual Cancer.新辅助化疗后影像引导下乳腺活检预测残余癌的准确性。
JAMA Surg. 2020 Dec 1;155(12):e204103. doi: 10.1001/jamasurg.2020.4103. Epub 2020 Dec 16.
8
Diagnosing Pathologic Complete Response in the Breast After Neoadjuvant Systemic Treatment of Breast Cancer Patients by Minimal Invasive Biopsy: Oral Presentation at the San Antonio Breast Cancer Symposium on Friday, December 13, 2019, Program Number GS5-03.通过微创活检诊断乳腺癌新辅助全身治疗后的病理完全缓解：2019 年 12 月 13 日星期五在圣安东尼奥乳腺癌研讨会上的口头报告，编号 GS5-03。
Ann Surg. 2022 Mar 1;275(3):576-581. doi: 10.1097/SLA.0000000000004246.
9
Prediction of pathologic complete response using image-guided biopsy after neoadjuvant chemotherapy in breast cancer patients selected based on MRI findings: a prospective feasibility trial.基于 MRI 表现选择的新辅助化疗后行影像引导下活检预测乳腺癌患者的病理完全缓解：一项前瞻性可行性研究。
Breast Cancer Res Treat. 2020 Jul;182(1):97-105. doi: 10.1007/s10549-020-05678-3. Epub 2020 May 16.
10
Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges.新辅助全身治疗后消除乳腺癌手术模式：当前证据和未来挑战。
Ann Oncol. 2020 Jan;31(1):61-71. doi: 10.1016/j.annonc.2019.10.012.